Analysis of competition and the level of dominance in the antidiabetics market of Russia

Introduction. Amid reports of a growing number of diabetic patients, the antidiabetics market players positioning is highly important for companies and the country’s leadership. The regulatory measures and management decisions depend on the competitive situation in the market.
Aim. Analysis of the changes in the level of dominance on the markets for antidiabetics and blood glucose monitors and meters.
Materials and methods. The distribution of these markets by product groups, as well as by commercial and public procurement segments has been taken into account. The Herfindahl-Hirschman and Linda indices, the adjusted Hall-Tideman index, concentration ratios and the SV matrix (strength/variety) were used as analysis tools, and the calculations were made on the basis of IQVIA data for the period from 2004 to the 3rd quarter of 2022.
Results. The dominance of three foreign companies that fell into the B4 and G quadrants was detected in the insulin and insulin analogues market. The glucose-lowering drugs market is the most competitive, it fell into the RO quadrant more often than other markets, and the dominant group, depending on the segment, included foreign and domestic companies with different frequency. The dominance of both three foreign and one Russian companies in the B4 and G quadrants, as well as a larger number of companies, was identified in the market for other alimentary tract and metabolism products. Several foreign and one Russian company that were identified into the B4 and G quadrants steadily dominated in the markets for blood glucose test strips, glucose monitors and meters and accessories, and lancets. 
Conclusions. The antidiabetics market is highly concentrated in its segments. The results show the historical development of the studied markets, the role of the commercial and public procurement segments in them, and serve as the foundation for studying the impact of environmental events on the Russian antidiabetics market.

1. Shen J. Diabetes & Endocrinology Market Analysis. J Rep Thyroid Research. 2021;5(2). Available at: https://www.hilarispublisher.com/open-access/diabetes--endocrinology-market-analysis.pdf.

2. Zaky M. Market Analysis of International Conference on Diabetes & Heart Diseases. J Diabetes Clinical practice. 2019;3(2). Available at: https://www.omicsonline.org/pdfdownload.php?download=open-access-pdfs/market-analysisof-international-conference-on-diabetes--heart-diseases.pdf&aid=110249.

3. Dolgopyatova Т., Fedyunina А., Nazarova А. Pharmaceutical production in Russia during the pandemic: chronic problems, new challenges. ECO. 2021;51(8):38–63. (In Russ.) https://doi.org/10.30680/ECO0131-7652-2021-8-38-63.

4. Manturov D.V. Industrial policy in the pharmaceutical industry of the Russian Federation. Ekonomicheskaya Politika. 2018;13(2):64–77. (In Russ.) https://doi.org/10.18288/1994-5124-2018-2-04.

5. Shevkunenko M. Strategic priorities of import substitution in the Russian pharmacological market. Newsletter of North-Caucasus Federal University. 2019;(3):117–124. (In Russ.) Available at: https://vestnikskfu.elpub.ru/jour/article/view/63/0.

6. Grishina I.V., Belchuk A.I., Sabelnikov L.V. Pharmaceuticals Imports in Russia. Russian Foreign Economic Journal. 2021;(3):69–76. (In Russ.) https://doi.org/10.24412/2072-8042-2021-3-69-76.

7. Markov N.I., Yakimova E.A. Analysis of competition and dominance in the russian pharmaceutical market. Pharmacoeconomics: Theory and Practice. 2022;10(4):22–33. (In Russ.) https://pharmacoeconom.com/en/articles/article_766.html.

8. Klimanov D., Tretyak O., Goren U., White T. Transformation of Value in Innovative Business Models: The Case of Pharmaceutical Market. Foresight and STI Governance. 2021;15(3):52–65. (In Russ.) https://doi.org/10.17323/2500-2597.2021.3.52.65.

9. Volgina N.A. Restructuring of Global Pharmaceutical Supply Chains after COVID-19. MGIMO Review of International Relations. 2022;15(1):126-142. (In Russ.) https://doi.org/10.24833/2071-8160-2022-1-82-126-142.

10. Glavina S.G., Aydrus I.A.Z. State and competitiveness of the Russian pharmaceutical industry under COVID-19 conditions. Ivecofin. 2021;4(50):70–81. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=47381210&ysclid=ldsoxnez3e537188655.

11. Kostin K.B., Shanava L.A. Key trends in the development of the Russian pharmaceutical market amidst uncertainty. Ekonomika, Predprinimatelstvo i Pravo. 2022;12(5):1639–1658. (In Russ.) https://doi.org/10.18334/epp.12.5.114635.

12. Lobuteva L., Lobuteva A., Zakharova O., Kartashova O., Kocheva N. The modern Russian pharmaceutical market: consumer attitudes towards distance retailing of medicines. BMC Health Serv Res. 2022;22(1):582. https://doi.org/10.1186/s12913-022-07991-7.

13. Vertogradov V.A., Shchelokova S.V. Is it possible to prove the existence of the “Big four” with figures in the Russian audit market? Audit. 2022;(1):15–21. (In Russ.) Available at: https://elibrary.ru/item.asp?id=47966782&ysclid=ldsoa1w5e7846280150.

14. Shchelokova S.V., Vertogradov V.A. SV matrix: strategic competitive analysis tool based on the dominance level. Moscow University Economics Bulletin. 2021;(6):137–162. (In Russ.) https://doi.org/10.38050/0130010520216.7.

15. Bukvic R.M., Pavlovic R.Z., Gajic A.M. Possibilities of Application of the Index Concentration of Linda in Small Economy, Example of Serbian Food Industries. Ann ORADEA Univ Fascicle Manag Technol Eng. 2014;23(13) (3):159–164. Available at: https://mpra.ub.uni-muenchen.de/81707/7/MPRA_paper_81707.pdf.

16. Linda R. Methodology of concentration analysis applied to the study of industries and markets. Brussel: ECSC/EEC/EAEC; 1976. 160 p. Available at: https://aei.pitt.edu/33888/1/A597.pdf.

17. Blokhin A.A., Lomakin-Rumyantsev I.V., Naumov S.A. Alpha Business in the Russian Food Market. Economic Strategies. 2019;144(6):68–77. (In Russ.) https://doi.org/10.33917/es-6.164.2019.68-77.

18. Spektor S. Competition in the Brazilian automotive market in 2011–2021. Latinskaia Amerika. 2022;(7):21. (In Russ.) https://doi.org/10.31857/S0044748X0019795-3.

19. Bartosh V.A., Lisetskaya I.R. Identification and analysis of dominant groups in the South African automotive market (2010-2021). Business Strategies. 2022;10(5):117–123. (In Russ.) https://doi.org/10.17747/2311-7184-2022-5-117-123.

20. Vertogradov V.A., Shchelokova S.V. Premium Car Brands Strategies and Regulator’s Actions in Russia (2009–2021). The World of New Economy. 2022;16(2):64–75. (In Russ.) https://doi.org/10.26794/2220-6469-2022-16-2-64-75.

21. Suslova I.P., Korostyleva I.I., Spektor S.V. Dominance of national systems of higher education. Economic Strategies. 2022;24(3):148–163. (In Russ.) https://doi.org/10.33917/es-3.183.2022.148-163.

22. Vertogradov V.A., Shchelokova S.V. The evolution of competition and Russia’s position in the global mineral fertilizer markets. AIC: Economics, Management. 2022;(9):91–103. (In Russ.) https://doi.org/10.33305/229-91.